Exelixis Clinical

Clinical research site in Chicago, Illinois · 2651 W DIVISION ST, 1ST FLOOR, CHICAGO, IL 60622 · (773) 252-1147

Part of Exelixis Clinical

As of July 2026, 2 paid clinical trials are recruiting at Exelixis Clinical in Chicago, Illinois. Active studies at this site cover conditions such as Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD and Renal Cell Carcinoma (RCC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Exelixis Clinical (2)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

for Neovascular Age-Related Macular Degeneration (nAMD)

79 locations incl. Mesa

Sponsor: Adverum Biotechnologies, Inc.

Sex: All·Age: 50+

Code: NCT07482176·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

for Renal Cell Carcinoma (RCC)

44 locations incl. Phoenix

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022

Apply to this trial

More research sites in Chicago

Northwestern University (341 trials)
University of Chicago (182 trials)
Rush University Medical Center (151 trials)
Ann & Robert H. Lurie Children's Hospital of Chicago (113 trials)
University of Chicago Medical Center (98 trials)
Northwestern Memorial Hospital (87 trials)
University of Chicago Comprehensive Cancer Center (87 trials)
University of Illinois (84 trials)
University of Illinois at Chicago (72 trials)
Advocate Illinois Masonic Medical Center (50 trials)

Explore more

Paid clinical trials in Chicago, IL · Illinois clinical trials